Ensign Peak Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
|
|||||
|
2025
Q1 | $6.28M | Hold |
|
|||||
|
2024
Q4 | $4.31M | Hold |
|
|||||
|
2024
Q3 | $4.45M | Sell |
|
|||||
|
2024
Q2 | $5.57M | Buy |
|
|||||
|
2024
Q1 | $5.87M | Sell |
|
|||||
|
2023
Q4 | $5.45M | Buy |
|
|||||
|
2023
Q3 | $11.8M | Buy |
|
|||||
|
2023
Q2 | $8.29M | Buy |
|
|||||
|
2023
Q1 | $6.72M | Buy |
|
|||||
|
2022
Q4 | $8.95M | Sell |
|
|||||
|
2022
Q3 | $5.79M | Buy |
|
|||||
|
2022
Q2 | $676K | Buy |
|
|||||
|
2022
Q1 | $359K | Hold |
|
|||||
|
2021
Q4 | $535K | Hold |
|
|||||
|
2021
Q3 | $565K | Hold |
|
|||||
|
2021
Q2 | $628K | Hold |
|
|||||
|
2021
Q1 | $733K | Hold |
|
|||||
|
2020
Q4 | $652K | Buy |
|
|||||
|
2020
Q3 | $595K | Sell |
|
|||||
|
2020
Q2 | $678K | Buy |
|
|||||
|
2020
Q1 | $324K | Sell |
|
|||||
|
2019
Q4 | $529K | Buy |
|